Evidence map›Paper›PMID 24729782›Full record

ArticleJournal of nanomaterials2013

Enhanced Ca

Michaela Schernthaner, Gerd Leitinger, Heimo Wolinski, Sepp D Kohlwein, Bettina Reisinger, Ruxandra-A Barb, Wolfgang F Graier, Johannes Heitz, Klaus Groschner

Open access · hybridAbstract read
In one paragraph

Article in Journal of nanomaterials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michaela SchernthanerInstitute of Biophysics, Medical University Graz, 8010 Graz, Austria.
Gerd LeitingerDepartment of Cell Biology, Histology and Embryology, Core Facility Ultrastructure Analysis, Center for Medical Research, Medical University Graz, 8010 Graz, Austria.
Heimo WolinskiInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Sepp D KohlweinInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Bettina ReisingerInstitute of Applied Physics, Johannes Kepler University Linz, 4040 Linz, Austria.
Ruxandra-A BarbInstitute of Applied Physics, Johannes Kepler University Linz, 4040 Linz, Austria.
Wolfgang F GraierInstitute of Molecular Biology and Biochemistry, Medical University Graz, 8010 Graz, Austria.
Johannes HeitzInstitute of Applied Physics, Johannes Kepler University Linz, 4040 Linz, Austria.
Klaus GroschnerInstitute of Biophysics, Medical University Graz, 8010 Graz, Austria.
Johannes Kepler University of Linz · ATMedical University of Graz · ATUniversity of Graz · AT

Funding

Austrian Science Fund FWF P 21925
6 · The paper itself

Abstract

Nanostructured substrates have been recognized to initiate transcriptional programs promoting cell proliferation. Specifically

Identifiers

PMID24729782
PMCPMC3982206
OpenAlexW1968901089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.